Abstract
Introduction/BackgroundEndometrial cancer (EC) is the most common gynaecological cancer in developed countries. Women with metastatic/recurrent EC have limited treatment options. Immunotherapy alone or in combination with either levantinib or chemotherapy...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
